Tech, Media & Telecom Roundup: Market Talk

Adagene completes enrollment in phase 2 trial of muzastotug

Investing.com · News 9m ago

Athena Gold increases private placement to $1.75 million

Investing.com · News 9m ago

Hemab initiates phase 3 trial for rare bleeding disorder drug

Investing.com · News 9m ago

Abcourt receives drilling permit for Malartic joint venture

Investing.com · News 9m ago

Viridian reports phase 1 results for VRDN-008 autoimmune drug

Investing.com · News 9m ago

Constellation shares up 4% in premarket trade on Q3 earnings beat, higher outlook

Investing.com · Investing_news 12m ago

Constellation shares up 4% in premarket trade on Q3 earnings beat, higher outlook

Investing.com · News 12m ago

Wedbush reiterates Protagonist Therapeutics stock rating on oral focus

Investing.com · News 13m ago

Stifel cuts Eos Energy stock price target on bookings concerns

Investing.com · News 13m ago

NRG earnings beat by $1.52, revenue topped estimates

Investing.com · News 16m ago